Related Experiment Videos
Development of a vector system for the expression of bioengineered proteins
J N Snouwaert1, R C Jambou, J E Skonier
1Department of Pathology, University of North Carolina, Chapel Hill 27599.
Clinical Chemistry
|July 1, 1989
Summary
Scientists engineered a high-yield synthetic gene for human interleukin 6 (IL-6), producing a bioengineered protein with therapeutic potential. This recombinant IL-6 protein retains key biological activities, overcoming natural abundance limitations for research and development.
Area of Science:
- Biotechnology
- Molecular Biology
- Protein Engineering
Background:
- Low natural abundance of therapeutic proteins like human interleukin 6 (IL-6) hinders their development.
- Synthetic biology offers a method to overcome limitations of natural protein production.
Purpose of the Study:
- To engineer a synthetic gene for high-level expression of a functional, bioengineered human interleukin 6 (IL-6) protein.
- To demonstrate the biological activity of the recombinant IL-6 protein.
Main Methods:
- Synthetic oligonucleotide technology was used to construct a gene for human IL-6.
- The gene encoded a cysteine-free, bioengineered rIL-6 protein expressed in Escherichia coli as a fusion protein.
- Collagenase cleavage released the purified 23-kDa rIL-6 protein.
Main Results:
- High-concentration expression of the bioengineered rIL-6 protein was achieved in E. coli.
- The purified rIL-6 protein exhibited biological activities comparable to natural human IL-6.
- Demonstrated activities include protection against viral infection and stimulation of fibrinogen synthesis.
Conclusions:
- Synthetic gene construction enables high-yield production of bioengineered interleukin 6.
- The resulting recombinant IL-6 protein is biologically active and suitable for further therapeutic and diagnostic applications.
- This approach addresses the challenge of low natural protein abundance for biotechnological use.